On a molecular mechanism level, one study found that EZH2 suppresses GDF-15 expression by binding to the GDF-15 promoter region and inducing H3K27 trimethylation, which may be related to the poor prognosis of NSCLC (31). This evidence concerns the gene EZH2 and non-small cell lung carcinoma.